leisure time -WSS

leisure time

author：explore 2025-09-30 23:40:53 - browse：29

Cathy McMorris Rodgers -- health policy coverage from STAT — Rep. Cathy McMorris Rodgers announced her plans to leave Congress at the end of 2024. Anna Moneymaker/Getty Images

WASHINGTON — Rep. Cathy McMorris Rodgers, the chair of a crucial House committee that handles health care issues, plans to leave Congress at the end of the year, she announced Thursday.

It will be a major shakeup for a panel already ravaged by Republican retirements. Reps. Michael Burgess (R-Texas), Larry Bucshon (R-Ind.), Jeff Duncan (R-S.C.), Debbie Lesko (R-Ariz.), Greg Pence (R-Ind.) and Kelly Armstrong (R-N.D.) are all leaving at the end of this Congress, too.

Under McMorris Rodgers, the panel led the way for House passage of a health care price transparency package that included the first major proposal to equalize payment between hospital outpatient departments and physician offices.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： How are insurers handling Leqembi and related scans?

focus

WSS

Private equity could exacerbate cardiology's overuse problem, experts fear

Cuban government calls US nuclear submarine stop a 'provocative escalation'

Food makers tried to stack nutrition panel with preferred experts

Antibody drugs appear effective. Now can we make enough of them?

France's anti

Hospitals consider fixing cancer drug shortages on their own

explore

leisure time

Wikipedia

Malaria cases in Florida and Texas: Here’s what you need to know

How medical schools plan to diversify without affirmative action

Tori Bowie and the unacceptable rates of Black maternal death

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Apple is now the first public company to be valued at $3 trillion

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

BioMarin wins approval for gene therapy to treat hemophilia A

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Drug repurposing or repositioning? The language matters

FDA proposes changes to key medical devices approval pathway

leisure time

PEPFAR is under serious threat — and so is global health

FDA approves updated Covid vaccines

Vermont grapples with historic flooding as more rainstorms head for Northeast

Companies helping big Covid

Companies helping big Covid

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

Wikipedia

focus

hotspot

explore